• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Transplant diagnostics Market

    ID: MRFR/MED/0816-CR
    100 Pages
    Rahul Gotadki
    July 2018

    Transplant diagnostics market Research Report Information By Product & Service (Instruments and Reagents & Consumables), By Screening Type (Pre-Transplant and Post-Transplant), By End User (Kidney, Liver, Heart, Lung, and Pancreas), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Transplant Diagnostics Market Research Report- Global Forecast Till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Transplant diagnostics Market Summary

    As per Market Research Future Analysis, the transplant diagnostics market was valued at USD 4.4 Billion in 2023 and is projected to grow to USD 8.3 Billion by 2032, with a CAGR of 7.3% from 2024 to 2032. The growth is driven by increasing public-private funding, rising infectious diseases, and advancements in technology. The reagents & consumables segment dominated the market in 2021, while the pre-transplant screening type held a majority share of 60-64%. The kidney segment led the organ type market due to a high number of kidney transplants. North America is expected to maintain a significant market share, supported by a developed healthcare system and high organ transplant volumes.

    Key Market Trends & Highlights

    Key trends driving the transplant diagnostics market include technological advancements and rising organ transplant procedures.

    • Market Size in 2023: USD 4.4 Billion; projected to reach USD 8.3 Billion by 2032.
    • CAGR of 7.3% during the forecast period (2024-2032).
    • Reagents & consumables segment dominated the market in 2021.
    • Pre-transplant screening accounted for 60-64% of market revenue in 2021.

    Market Size & Forecast

    2023 Market Size USD 4.4 Billion
    2032 Market Size USD 8.3 Billion
    CAGR 7.3%

    Major Players

    Key players include Becton Dickinson and Company, Bio-Rad Laboratories Inc, Illumina Inc, Immucor Transplant Diagnostics Inc, Thermo Fisher Scientific Inc, CareDx, and QIAGEN NV.

    Transplant diagnostics Market Trends

      • Rising prevalence of chronic diseases to drive market growth

    Globally, the rising prevalence of chronic diseases is subsequently increasing the incidence of organ failure, further surging the need for organ transplants. The Organ Donor states that over 1 million tissue transplants are performed every year. The geriatric population is highly susceptible to chronic diseases, which further increases the need for organ transplantation. As per the World Health Organization (WHO), by 2050, the world’s population aged 60 and older is expected to reach 2 billion, from 900 million in 2015. 

    Chronic kidney disease (CKD) is highly prevalent and the leading cause of kidney transplantation procedures. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) states that about 661,000 Americans have Kidney failure. About 468,000 people are on dialysis, and roughly 193,000 people live with a kidney transplant.

    Increased transplant diagnostic testing will result from increased organ donation, propelling industry growth. Additionally, several significant players are releasing new products on the market, which is anticipated to further fuel market revenue. For instance, in September 2021, Thermo Fisher Scientific added two new products to its range of transplant diagnostics during the American Society for Histocompatibility and Immunogenetics (ASHI) annual meeting.

    The increasing prevalence of organ transplantation, coupled with advancements in diagnostic technologies, appears to be driving the evolution of the transplant diagnostics market, enhancing patient outcomes and optimizing transplant success rates.

    U.S. Department of Health and Human Services

    Transplant diagnostics Market Drivers

    Increased Awareness and Education

    There is a growing awareness regarding the importance of organ donation and transplantation, driven by educational campaigns and advocacy efforts. This heightened awareness is fostering a more supportive environment for organ donation, which in turn boosts the demand for transplant diagnostics. The Global Transplant Diagnostics Market Industry is likely to see an increase in engagement from both healthcare providers and the public, leading to improved transplant rates. This trend suggests a robust growth trajectory, with a projected CAGR of 7.31% from 2025 to 2035.

    Regulatory Support and Guidelines

    Governmental bodies and health organizations are increasingly establishing regulations and guidelines to promote safe and effective transplant practices. These regulations often include standards for transplant diagnostics, ensuring that testing methods are reliable and up to date. The Global Transplant Diagnostics Market Industry is positively influenced by this regulatory framework, as it encourages the adoption of advanced diagnostic technologies. As compliance with these guidelines becomes essential, the market is expected to expand, reflecting the growing emphasis on patient safety and quality of care.

    Market Trends and Growth Projections

    Emerging Markets and Global Expansion

    Emerging markets are becoming increasingly important in the Global Transplant Diagnostics Market Industry. Countries with developing healthcare infrastructures are investing in transplant programs and diagnostic technologies, driven by rising healthcare expenditures. This expansion is creating new opportunities for market players to introduce their products and services. As these markets grow, they may contribute significantly to the overall market value, which is projected to reach 10.3 USD Billion by 2035. The potential for growth in these regions indicates a dynamic shift in the global landscape of transplant diagnostics.

    Rising Incidence of Organ Transplants

    The increasing prevalence of chronic diseases and organ failures has led to a surge in the demand for organ transplants. This trend is particularly evident in regions with aging populations, where conditions such as diabetes and cardiovascular diseases are more common. The Global Transplant Diagnostics Market Industry is responding to this demand, as evidenced by the projected market value of 4.72 USD Billion in 2024. As healthcare systems adapt to these challenges, the need for effective transplant diagnostics becomes paramount, ensuring compatibility and improving patient outcomes.

    Technological Advancements in Diagnostics

    Innovations in molecular diagnostics and genetic testing are transforming the landscape of transplant diagnostics. Technologies such as next-generation sequencing and real-time PCR are enhancing the accuracy of donor-recipient matching. These advancements not only improve the success rates of transplants but also streamline the diagnostic processes. The Global Transplant Diagnostics Market Industry is likely to benefit from these technological developments, as they facilitate more personalized medicine approaches. As a result, the market is expected to grow significantly, potentially reaching 10.3 USD Billion by 2035.

    Market Segment Insights

    Transplant Diagnostics Product & Service Insights

    The market segments of transplant diagnostics, based on the product & service, includes instruments and reagents & consumables. The reagents & consumables segment dominated the global market in 2021. Higher consumption rate of these products across all applications and end-uses along with greater replacements rates despite less cost is the key attribute of this segment. Manufacturers of these type of diagnostic products are adopting strategies such as purchase contracts for reagents and consumables. In addition, the key factor accelerating the adoption of reagents and consumables is their repeat purchase. 

    The large share of this segment can be further attributed to the rapid modernization and automation of diagnostic laboratories, growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories, and the growing number of organ transplantation procedures.

    Transplant Diagnostics Screening Type Insights

    The transplant diagnostics market segmentation, based on the screening type, includes pre-transplant and post-transplant. The pre-transplant segment held the majority share in 2021, contributing to around ~60-64% of the market revenue of transplant diagnostics. These pre-transplantation analysis techniques are employed to ensure safe and effective procedures. Factors such as growing awareness among physicians and rapidly adopting technologically advanced tools are expected to drive growth in the coming years. 

    Further, growing geriatric population susceptible to the various chronic diseases due to weaker immunity are the key factors supporting the market growth of the pre-transplant diagnostics for diagnostic applications.

    Transplant Diagnostics Screening Type 2021 and 2030

    Transplant Diagnostics Screening Type 2021 and 2030 Transplant Diagnostics Organ Type Insights

    The market segmentation of transplant diagnostics, based on the organ type, includes kidney, liver, heart, lung, and pancreas. The kidney segment had the highest market revenue share in 2021. Increasing number of kidney transplantation procedures coupled with the supportive government regulations to augment organ donations across major healthcare markets supporting the segmental growth of the market. Kidney and liver transplants are more prevalent applications in the serological transplant diagnostic market fueled by the rise in incidences of kidney and liver failure in the geriatric population. 

    Especially, in those with chronic diseases. As per the reports published by the American Society of Nephrology titled- Chronic Kidney Disease in India, the range of CKD in India ranges from 1% to 13%.

    January 2019: 

    Get more detailed insights about Transplant Diagnostics Market Research Report- Global Forecast Till 2032

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Transplant Diagnostics market is expected to grow at a significant CAGR during the study period, accounting for USD 4.95 billion in 2021. North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics are the major factors driving the market in North America. 

    Further, the presence of many patients pool, who needs transplant treatment is helping to grow the market at a sustainable rate in this region.

    Transplant Diagnostics market SHARE BY REGION 2021 Transplant Diagnostics market SHARE BY REGION 2021

    Moreover, the major countries covered in the market report include the United States, Germany, Canada, France, the United Kingdom, Italy, Spain, India, Japan, Australia, China, South Korea, and Brazil.

    The European Transplant Diagnostics market is the world's second-largest. Major drivers include the high adoption of advanced techniques and diagnostic tools, higher healthcare expenditure, and availability of skilled professionals. The U.K. holds the largest market share owing to factors such as highly developed healthcare infrastructure and the availability of skilled professionals. Moreover, the high adoption of personalized medicines, stem cell therapies, and soft tissue transplants are augmenting the regional market growth. 

    Increase in awareness among people related to the importance of organ transplantation has been an ongoing trend in the European countries. This has resulted in increasing number of organ donations especially from living donors. Further, the UK market of Transplant Diagnostics held the largest market share, and the German market of Transplant Diagnostics was the fastest-growing market in the European region.

    The Asia Pacific Transplant Diagnostics market is expected to grow at the fastest CAGR during the forecast period. This is due to the rising number of organ transplants, donors, and the government's support in developing the transplant diagnosis market in the region. The Asia Pacific comprises a large pool of patient population and developing advanced healthcare infrastructure. 

    A vast rise in the prevalence of several chronic diseases and the resultant rise in transplant procedures, coupled with the availability of vast untapped growth opportunities in this region will attract many companies in the upcoming years. Moreover, China’s market of Transplant Diagnostics held the largest market share, and the Indian market of Transplant Diagnostics was the fastest-growing market in Asia-Pacific.

    Key Players and Competitive Insights

    The global market is highly competitive with very few players competing in the international market. The quality and accuracy constraints of transplant diagnostic techniques like serology-based and PCR-based HLA typing increase the overall cost of products. As a result, players are implementing strategies, such as long-term contracts with diagnostic clinics and laboratories and discount pricing for bulk purchases.

    Companies in the in the market of Transplant Diagnostics are using the

    Next Generation Sequencing

    (NGS) for conducting tests to match organ donors and recipients. NGS technology allows the sequencing of an entire human genome, i.e., millions of DNA molecules within a single day. In Next-generation sequencing (NSG), genes are matched between the donor and recipient and depending on the extent of match, decision to perform organ transplantation is made. Nearly all transplant diagnostic tests and devices currently use this technology to decide on organ transplantation. For example, Castle Biosciences launched Decision Dx-CMSeq Test that used NGS (Next Generation Sequencing) to identify somatic mutations in genes.

    Eurofins Scientific SE is a French group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments. In June 2019, Eurofins Scientific acquired Transplant Genomics Inc to improve organ transplant outcomes with non-invasive serial monitoring guided by genomics.

    Immucor Inc is a global in vitro diagnostics company specializing in the area of pre-transfusion diagnostics. The company offers a complete line of serology-based reagents and instruments used by hospitals, reference labs and donor centers to perform pre-transfusion typing and screening of blood and renders blood bank software solutions that are designed specifically to enhance the productivity of blood bank laboratories, providing transfusion test results in an efficient and productive way to the customers. 

    In March 2022, Immucor, Inc., a company focused on transfusion and transplantation diagnostics, announced two additions to its transplant diagnostics portfolio, demonstrating its ongoing commitment to new advancements in the field of histocompatibility.

    Key Companies in the Transplant diagnostics Market market include

    Industry Developments

    • Q1 2024: Immucor, Inc. introduces two new products to its transplant diagnostics line Immucor, Inc., a specialist in transfusion and transplantation diagnostics, launched two new products in March 2022 to expand its transplant diagnostics portfolio, demonstrating ongoing innovation in the histocompatibility sector.

    Future Outlook

    Transplant diagnostics Market Future Outlook

    The Global Transplant Diagnostics Market is projected to grow at a 7.31% CAGR from 2024 to 2035, driven by technological advancements, increasing organ transplant procedures, and rising awareness of transplant compatibility.

    New opportunities lie in:

    • Develop innovative molecular diagnostics to enhance transplant success rates.
    • Expand telehealth services for pre- and post-transplant patient management.
    • Invest in AI-driven data analytics for personalized transplant matching solutions.

    By 2035, the market is expected to achieve substantial growth, reflecting advancements in transplant diagnostics.

    Market Segmentation

    Transplant Diagnostics Regional Outlook

    North America
    • US
    • Canada

    Transplant Diagnostics Organ Type Outlook

    • Kidney
    • Liver
    • Heart
    • Lung
    • Pancreas

    Transplant Diagnostics Screening Type Outlook

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Product & Service Outlook

    • Instruments
    • Reagents & Consumables

    Report Scope

    Attribute/Metric Details
    Market Size 2023 USD 4.4 billion
    Market Size 2024 USD 4.72 billion
    Market Size 2032 USD 8.3 billion
    Compound Annual Growth Rate (CAGR) 7.3% (2024-2032)
    Base Year 2021
    Market Forecast Period 2024-2032
    Historical Data 2018 & 2020
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product & Service, Screening Type, Organ Type, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Becton Dickinson and Company (U.S.), Bio-Rad Laboratories Inc (U.S.), Illumina Inc (U.S.), Immucor Transplant Diagnostics Inc (U.S.), Thermo Fisher Scientific Inc (U.S.), CareDx (U.S.), Affymetrix Inc (U.S.), Linkage Biosciences (U.S.), Abbott Laboratories Inc (U.S.), BioMérieux S.A. (France), QIAGEN NV (Netherlands)
    Key Market Opportunities Increasing prevalence of chronic illnesses among the worldwide population
    Key Market Dynamics Growing incidence of organ failure to favor the market Rising adoption of stem cell therapy and customized drugs is gaining a reputation

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How much is the Transplant Diagnostics market?

    The transplant diagnostics market size was valued at USD 4.4 Billion in 2023.

    What is the growth rate of the Transplant Diagnostics market?

    The global market is projected to grow at a CAGR of 7.3% during the forecast period, 2024-2032.

    Which region held the largest market share in the Transplant Diagnostics market?

    North America had the largest share of the global market.

    Who are the key players in the Transplant Diagnostics market?

    The key players in the market are Becton Dickinson and Company (U.S.), Bio-Rad Laboratories Inc (U.S.), Illumina Inc (U.S.), Immucor Transplant Diagnostics Inc (U.S.), Thermo Fisher Scientific Inc (U.S.), CareDx (U.S.), Affymetrix Inc (U.S.), Linkage Biosciences (U.S.), Abbott Laboratories Inc (U.S.), BioMérieux S.A. (France), and QIAGEN NV (Netherlands).

    Which product & services led the Transplant Diagnostics market?

    The reagents & consumables category dominated the market in 2021.

    Which screening type had the largest market share in the Transplant Diagnostics market?

    In 2021, pre-transplant had the largest share of the global market.

    1. Report Prologue
    2. Executive Summary
    3. Market Introduction
      1. Scope of Study 25
      2. Research Objective 25
      3. List of Assumptions
      4. Market Structure 26
    4. Research Methodology
      1. Primary
    5. Research Methodology 29
      1. Data points received from the Specialist Doctors:
      2. Data points received from the Manufacturer/ Pharmaceutical Companies:
      3. Data points received from Hospitals, Diagnostic Centers: 31
    6. Secondary Research Methodology 32
      1. Market Share Analysis 33
      2. Trade
    7. Analysis 34
      1. Market Pricing Approach 34
      2. Forecast Model 35
    8. Market Dynamics
      1. Introduction 37
      2. Drivers 38
        1. Growing
    9. number of stem cell, soft-tissue, and solid organ, transplantation procedures 38
      1. Rising occurrence of chronic and infectious diseases 38
        1. Increasing
    10. Awareness Related to Transplant Diagnostic Procedures 38
      1. Restraints 39
        1. Shortage of donor organ and limited medical reimbursement 39
    11. High cost of NGS- and PCR-based devices 39
      1. Opportunities 40
    12. High demand for tissue engineering in cosmetic and reconstructive surgery 40
      1. Growing geriatric population presents a significant growth opportunity 40
    13. Market Factor Analysis
      1. Porters Five Forces Analysis 42
    14. Bargaining Power of Suppliers 42
      1. Bargaining Power of Buyers 43
    15. Threat of New Entrants 43
      1. Threat of Substitutes 43
        1. Intensity
    16. of Rivalry 43
      1. Supply Chain Analysis 44
        1. Primary activities 44
        2. Secondary Activities 45
    17. Immunosuppressant Drug Monitoring (ISD)
      1. Overview 47
      2. Diagnostic Tests for Transplantation 47
        1. Therapeutic
    18. Drug Monitoring During Transplantation 47
      1. Americas 48
        1. North
    19. America 48
      1. U.S. 50
        1. Canada 51
        2. South America
      2. Europe 53
        1. Germany 54
        2. U.K 55
        3. France
        4. Spain 57
        5. Italy 58
        6. Rest of Europe 59
    20. Asia Pacific 61
      1. China 62
        1. Japan 63
        2. India 64
    21. Australia 65
      1. Rest of Asia Pacific 66
      2. Middle East & Africa
        1. Middle East 69
        2. Africa 70
    22. Transplant Diagnostics
    23. Market, By Products and Services
      1. Introduction 73
        1. Instruments
        2. Reagents & Consumables 76
        3. Software and Services 76
    24. Transplant Diagnostics Market, By Screening Type
      1. Introduction
        1. Pre-Transplant Screening 79
        2. Post-Transplant Screening 79
    25. Transplant Diagnostics Market, By Organ Type
      1. Introduction 81
        1. Kidney 82
        2. Liver 82
        3. Heart 83
        4. Lung 83
        5. Pancreas 83
    26. Transplant Diagnostics Market, By Application
    27. Type
      1. Introduction 85
        1. Research Applications 86
    28. Diagnostic Applications 86
    29. Transplant Diagnostics Market, By End User
      1. Introduction 88
        1. Commercial Service Providers 89
        2. Hospitals
    30. and Transplant Centres 89
      1. Research Laboratories and Academic Institutes
    31. Global Transplant Diagnostics Market, By Region
      1. Introduction
      2. Americas 92
    32. Transplant Diagnostics Market, By Products and Services
    33. Transplant Diagnostics Market, By Screening Type
    34. Transplant Diagnostics Market,
    35. By Organ Type
    36. Transplant Diagnostics Market, By Application Type
    37. Transplant
    38. Diagnostics Market, By End User
      1. North America 93
    39. Transplant Diagnostics
    40. Market, By Products and Services
    41. Transplant Diagnostics Market, By Screening
    42. Type
    43. Transplant Diagnostics Market, By Organ Type
    44. Transplant Diagnostics
    45. Market, By Application Type
    46. Transplant Diagnostics Market, By End User
    47. U.S. 97
    48. Transplant Diagnostics Market, By Products and Services
    49. Transplant
    50. Diagnostics Market, By Screening Type
    51. Transplant Diagnostics Market, By Organ
    52. Type
    53. Transplant Diagnostics Market, By Application Type
    54. Transplant Diagnostics
    55. Market, By End User
      1. Canada 100
    56. Transplant Diagnostics Market,
    57. By Products and Services
    58. Transplant Diagnostics Market, By Screening Type
    59. Transplant Diagnostics Market, By Organ Type
    60. Transplant Diagnostics Market,
    61. By Application Type
    62. Transplant Diagnostics Market, By End User
    63. South America 104
    64. Transplant Diagnostics Market, By Products and Services
    65. Transplant Diagnostics Market, By Screening Type
    66. Transplant Diagnostics Market,
    67. By Organ Type
    68. Transplant Diagnostics Market, By Application Type
    69. Transplant
    70. Diagnostics Market, By End User
      1. Europe 108
    71. Transplant Diagnostics
    72. Market, By Products and Services
    73. Transplant Diagnostics Market, By Screening
    74. Type
    75. Transplant Diagnostics Market, By Organ Type
    76. Transplant Diagnostics
    77. Market, By Application Type
    78. Transplant Diagnostics Market, By End User
    79. Germany 112
    80. Transplant Diagnostics Market, By Products and Services
    81. Transplant
    82. Diagnostics Market, By Screening Type
    83. Transplant Diagnostics Market, By Organ
    84. Type
    85. Transplant Diagnostics Market, By Application Type
    86. Transplant Diagnostics
    87. Market, By End User
      1. U.K 116
    88. Transplant Diagnostics Market, By Products
    89. and Services
    90. Transplant Diagnostics Market, By Screening Type
    91. Transplant
    92. Diagnostics Market, By Organ Type
    93. Transplant Diagnostics Market, By Application
    94. Type
    95. Transplant Diagnostics Market, By End User
      1. France 119
    96. Transplant
    97. Diagnostics Market, By Products and Services
    98. Transplant Diagnostics Market,
    99. By Screening Type
    100. Transplant Diagnostics Market, By Organ Type
    101. Transplant
    102. Diagnostics Market, By Application Type
    103. Transplant Diagnostics Market, By End
    104. User
      1. Spain 123
    105. Transplant Diagnostics Market, By Products and Services
    106. Transplant Diagnostics Market, By Screening Type
    107. Transplant Diagnostics Market,
    108. By Organ Type
    109. Transplant Diagnostics Market, By Application Type
    110. Transplant
    111. Diagnostics Market, By End User
      1. Italy 126
    112. Transplant Diagnostics
    113. Market, By Products and Services
    114. Transplant Diagnostics Market, By Screening
    115. Type
    116. Transplant Diagnostics Market, By Organ Type
    117. Transplant Diagnostics
    118. Market, By Application Type
    119. Transplant Diagnostics Market, By End User
    120. Rest of Europe 130
    121. Transplant Diagnostics Market, By Products and Services
    122. Transplant Diagnostics Market, By Screening Type
    123. Transplant Diagnostics Market,
    124. By Organ Type
    125. Transplant Diagnostics Market, By Application Type
    126. Transplant
    127. Diagnostics Market, By End User
      1. Asia Pacific 134
    128. Transplant Diagnostics
    129. Market, By Products and Services
    130. Transplant Diagnostics Market, By Screening
    131. Type
    132. Transplant Diagnostics Market, By Organ Type
    133. Transplant Diagnostics
    134. Market, By Application Type
    135. Transplant Diagnostics Market, By End User
    136. China 138
    137. Transplant Diagnostics Market, By Products and Services
    138. Transplant
    139. Diagnostics Market, By Screening Type
    140. Transplant Diagnostics Market, By Organ
    141. Type
    142. Transplant Diagnostics Market, By Application Type
    143. Transplant Diagnostics
    144. Market, By End User
      1. Japan 142
    145. Transplant Diagnostics Market, By
    146. Products and Services
    147. Transplant Diagnostics Market, By Screening Type
    148. Transplant
    149. Diagnostics Market, By Organ Type
    150. Transplant Diagnostics Market, By Application
    151. Type
    152. Transplant Diagnostics Market, By End User
      1. India 145
    153. Transplant
    154. Diagnostics Market, By Products and Services
    155. Transplant Diagnostics Market,
    156. By Screening Type
    157. Transplant Diagnostics Market, By Organ Type
    158. Transplant
    159. Diagnostics Market, By Application Type
    160. Transplant Diagnostics Market, By End
    161. User
      1. Australia 149
    162. Transplant Diagnostics Market, By Products and
    163. Services
    164. Transplant Diagnostics Market, By Screening Type
    165. Transplant Diagnostics
    166. Market, By Organ Type
    167. Transplant Diagnostics Market, By Application Type
    168. Transplant Diagnostics Market, By End User
      1. Rest of Asia Pacific 152
    169. Transplant Diagnostics Market, By Products and Services
    170. Transplant Diagnostics
    171. Market, By Screening Type
    172. Transplant Diagnostics Market, By Organ Type
    173. Transplant
    174. Diagnostics Market, By Application Type
    175. Transplant Diagnostics Market, By End
    176. User
      1. Middle East & Africa 156
    177. Transplant Diagnostics Market,
    178. By Products and Services
    179. Transplant Diagnostics Market, By Screening Type
    180. Transplant Diagnostics Market, By Organ Type
    181. Transplant Diagnostics Market,
    182. By Application Type
    183. Transplant Diagnostics Market, By End User
    184. Middle East 160
    185. Transplant Diagnostics Market, By Products and Services
    186. Transplant Diagnostics Market, By Screening Type
    187. Transplant Diagnostics Market,
    188. By Organ Type
    189. Transplant Diagnostics Market, By Application Type
    190. Transplant
    191. Diagnostics Market, By End User
      1. Africa 164
    192. Transplant Diagnostics
    193. Market, By Products and Services
    194. Transplant Diagnostics Market, By Screening
    195. Type
    196. Transplant Diagnostics Market, By Organ Type
    197. Transplant Diagnostics
    198. Market, By Application Type
    199. Transplant Diagnostics Market, By End User
    200. Competitive Landscape
      1. Company Market Share Analysis 169
        1. Introduction
      2. Competitive Landscape 170
        1. Introduction 170
      3. Key
    201. Developments 171
    202. Company Profiles
      1. Thermo Fisher Scientific
    203. Inc. 175
      1. Company Overview 175
        1. Financial Overview 175
        2. Products Offering 176
        3. Key Developments 176
        4. SWOT
    204. Analysis 176
      1. Key Strategy 177
      2. Bio-Rad Laboratories, Inc. 178
        1. Company Overview 178
        2. Financial Overview 178
        3. Products
    205. Offering 179
      1. Key Developments 179
        1. SWOT Analysis 179
    206. Key Strategy 180
      1. F. Hoffmann-La Roche AG 181
        1. Company Overview
        2. Financial Overview 181
        3. Products Offering 182
    207. Key Developments 182
      1. SWOT Analysis 183
        1. Key Strategy 183
      2. Qiagen N.V. 184
        1. Company Overview 184
        2. Financial Overview
        3. Products Offering 185
        4. Key Developments 185
    208. SWOT Analysis 185
      1. Key strategy 185
      2. BioMérieux SA 186
        1. Company Overview 186
        2. Financial Overview 186
        3. Products
    209. Offering 187
      1. Key Developments 187
        1. SWOT Analysis 187
    210. Key Strategy 187
      1. Illumina, Inc. 188
        1. Company Overview 188
        2. Financial Overview 188
        3. Products Offering 189
        4. Key
    211. Developments 189
      1. SWOT Analysis 190
        1. Key Strategy 190
    212. Becton, Dickinson and Company 191
      1. Company Overview 191
        1. Financial
    213. Overview 191
      1. Products Offering 192
        1. Key Developments 192
        2. SWOT Analysis 192
        3. Key Strategy 193
      2. Caredx, Inc. 194
        1. Company Overview 194
        2. Financial Overview 194
        3. Products
    214. Offering 195
      1. Key Developments 195
        1. SWOT Analysis 195
    215. Key Strategy 196
      1. Gendx 197
        1. Company Overview 197
    216. Financial Overview 197
      1. Products Offering 197
        1. Key Developments
        2. SWOT Analysis 198
        3. Key Strategy 198
      2. Zimmer
    217. Biomet 199
      1. Company Overview 199
        1. Financial Overview 199
        2. Products Offering 200
        3. Key Developments 200
        4. SWOT
    218. Analysis 200
      1. Key Strategy 200
      2. Medtronic PLC 201
    219. Company Overview 201
      1. Financial Overview 201
        1. Products Offering
        2. Key Developments 202
        3. SWOT Analysis 202
    220. Key Strategy 202
      1. DiaSorin S.P.A 203
        1. Company Overview 203
        2. Financial Overview 203
        3. Products Offering 204
    221. Key Developments 204
      1. SWOT Analysis 204
        1. Key Strategy 204
      2. Merck KGaA 205
        1. Company Overview 205
        2. Financial
    222. Overview 205
      1. Products Offering 206
        1. Key Developments 206
        2. SWOT Analysis 206
        3. Key Strategy 207
      2. Immucor, Inc.
        1. Company Overview 208
        2. Financial Overview: 208
    223. Products Offering 208
      1. Key Developments 208
        1. SWOT Analysis
        2. Key strategy 209
    224. Appendix
      1. Discussion Blue
    225. Print 211
      1. Reference 214
    226. List of Tables
    227. SYNOPSIS 22
    228. (USD MILLION) 47
    229. 2027 (USD MILLION) 48
    230. BY COUNTRY 2020-2027 (USD MILLION) 48
    231. DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
    232. 2027 (USD MILLION) 48
    233. DRUG
    234. 2027 (USD MILLION) 49
    235. DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 49
    236. IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD
    237. MILLION) 50
    238. DRUG 2020-2027 (USD MILLION) 50
    239. MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 50
    240. DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 51
    241. CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
    242. (USD MILLION) 51
    243. BY TEST TYPE 2020-2027 (USD MILLION) 51
    244. DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
    245. 2027 (USD MILLION) 52
    246. DRUG
    247. 2027 (USD MILLION) 52
    248. DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 52
    249. TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 53
    250. EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027
    251. (USD MILLION) 53
    252. BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 53
    253. DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 54
    254. IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD
    255. MILLION) 54
    256. DRUG 2020-2027 (USD MILLION) 54
    257. MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 55
    258. MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 55
    259. DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 55
    260. MILLION) 56
    261. HLA TYPING 2020-2027 (USD MILLION) 56
    262. MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 56
    263. FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD
    264. MILLION) 57
    265. HLA TYPING 2020-2027 (USD MILLION) 57
    266. MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 57
    267. SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION)
    268. TYPING 2020-2027 (USD MILLION) 58
    269. MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 58
    270. (USD MILLION) 58
    271. ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION)
    272. HLA TYPING
    273. 2027 (USD MILLION) 59
    274. DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
    275. 2027 (USD MILLION) 59
    276. 2027 (USD MILLION) 60
    277. BY COUNTRY 2020-2027 (USD MILLION) 61
    278. DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 61
    279. ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
    280. 2027 (USD MILLION) 61
    281. MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 62
    282. DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 62
    283. CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
    284. (USD MILLION) 62
    285. TEST TYPE 2020-2027 (USD MILLION) 63
    286. MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 63
    287. JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
    288. (USD MILLION) 63
    289. TEST TYPE 2020-2027 (USD MILLION) 64
    290. MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 64
    291. INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027
    292. (USD MILLION) 64
    293. TEST TYPE 2020-2027 (USD MILLION) 65
    294. MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 65
    295. AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
    296. 2027 (USD MILLION) 65
    297. MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 66
    298. DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 66
    299. REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
    300. 2027 (USD MILLION) 66
    301. MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 67
    302. AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2020-2027 (USD MILLION)
    303. BY MOLECULAR HLA TYPING
    304. 2027 (USD MILLION) 68
    305. & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
    306. 2027 (USD MILLION) 68
    307. DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 69
    308. EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027
    309. (USD MILLION) 69
    310. BY IMMUNOSUPPRESSANT DRUG
    311. 2027 (USD MILLION) 69
    312. IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 70
    313. 2027 (USD MILLION) 70
    314. MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 70
    315. IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 71
    316. (USD MILLION) 73
    317. & CONSUMABLES 2020-2027 (USD MILLION) 74
    318. MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 74
    319. DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 74
    320. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION)
    321. 2027 (USD MILLION) 75
    322. INSTRUMENTS, BY REGION 2020-2027 (USD MILLION) 75
    323. DIAGNOSTICS MARKET FOR REAGENTS & CONSUMABLES, BY REGION 2020-2027 (USD MILLION)
    324. BY REGION 2020-2027 (USD MILLION) 76
    325. MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 78
    326. DIAGNOSTICS MARKET FOR PRE-TRANSPLANT SCREENING, BY REGION 2020-2027 (USD MILLION)
    327. BY REGION 2020-2027 (USD MILLION) 79
    328. MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 81
    329. DIAGNOSTICS MARKET FOR KIDNEY, BY REGION 2020-2027 (USD MILLION) 82
    330. GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY REGION 2020-2027 (USD MILLION)
    331. (USD MILLION) 83
    332. REGION 2020-2027 (USD MILLION) 83
    333. FOR PANCREAS, BY REGION 2020-2027 (USD MILLION) 83
    334. DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 85
    335. TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION)
    336. BY REGION 2020-2027 (USD MILLION) 86
    337. MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION 2020-2027 (USD MILLION) 86
    338. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 88
    339. BY REGION 2020-2027 (USD MILLION) 89
    340. MARKET FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION
    341. 2027 (USD MILLION)
    342. AND ACADEMIC INSTITUTES, BY REGION
    343. 2027 (USD MILLION) 89
    344. GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020-2027 (USD MILLION) 91
    345. AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020-2027 (USD MILLION) 92
    346. MILLION) 93
    347. AND SERVICES 2020-2027 (USD MILLION) 93
    348. DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 94
    349. (USD MILLION) 94
    350. MOLECULAR ASSAY 2020-2027 (USD MILLION) 94
    351. DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 94
    352. NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027
    353. (USD MILLION) 95
    354. SCREENING TYPE 2020-2027 (USD MILLION) 95
    355. DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 95
    356. AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 96
    357. 2027 (USD MILLION) 96
    358. BY END USER 2020-2027 (USD MILLION) 96
    359. MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 97
    360. TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION)
    361. (USD MILLION) 97
    362. ASSAY 2020-2027 (USD MILLION) 97
    363. BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 98
    364. MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 98
    365. TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 98
    366. U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 99
    367. 2027 (USD MILLION) 99
    368. END USER 2020-2027 (USD MILLION) 100
    369. MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 100
    370. TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION)
    371. (USD MILLION) 101
    372. ASSAY 2020-2027 (USD MILLION) 101
    373. BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 101
    374. DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 101
    375. CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION)
    376. (USD MILLION) 102
    377. 2027 (USD MILLION) 102
    378. BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 103
    379. DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 103
    380. AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION)
    381. CONSUMABLES 2020-2027 (USD MILLION) 104
    382. DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 104
    383. SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION)
    384. 2027 (USD MILLION) 105
    385. MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 105
    386. AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION)
    387. (USD MILLION) 106
    388. APPLICATION 2020-2027 (USD MILLION) 106
    389. DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 106
    390. SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION)
    391. MILLION) 108
    392. SERVICES 2020-2027 (USD MILLION) 109
    393. MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 109
    394. EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION)
    395. (USD MILLION) 109
    396. ASSAY 2020-2027 (USD MILLION) 110
    397. BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 110
    398. DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 110
    399. EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 111
    400. MILLION) 111
    401. APPLICATIONS 2020-2027 (USD MILLION) 111
    402. MARKET, BY END USER 2020-2027 (USD MILLION) 112
    403. DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 112
    404. GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027
    405. (USD MILLION) 112
    406. & KITS 2020-2027 (USD MILLION) 113
    407. MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 113
    408. DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 113
    409. GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD
    410. MILLION) 113
    411. TYPE 2020-2027 (USD MILLION) 114
    412. BY ORGAN TYPE 2020-2027 (USD MILLION) 114
    413. MARKET, BY APPLICATION 2020-2027 (USD MILLION) 114
    414. DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 115
    415. GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 115
    416. (USD MILLION) 116
    417. & CONSUMABLES 2020-2027 (USD MILLION) 116
    418. MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 116
    419. DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 116
    420. U.K TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 117
    421. (USD MILLION) 117
    422. TYPE 2020-2027 (USD MILLION) 117
    423. BY ORGAN TYPE 2020-2027 (USD MILLION) 118
    424. MARKET, BY APPLICATION 2020-2027 (USD MILLION) 118
    425. DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 118
    426. U.K TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 119
    427. (USD MILLION) 119
    428. & CONSUMABLES 2020-2027 (USD MILLION) 119
    429. MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 120
    430. DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 120
    431. FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION)
    432. 2027 (USD MILLION) 120
    433. BY SCREENING TYPE 2020-2027 (USD MILLION) 121
    434. MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 121
    435. DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 121
    436. TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (U

    Market Segmentation Tab

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
    • Pancreas

    Transplant Diagnostics Regional Outlook (USD Billion, 2018-2030)

    • North America Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • US Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • CANADA Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Europe Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Germany Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • France Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • UK Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • ITALY Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • SPAIN Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Rest Of Europe Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Asia-Pacific Outlook (USD Billion, 2018-2030)

     Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
    • Pancreas
      • China Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Japan Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • India Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Australia Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Rest of the World Outlook (USD Billion, 2018-2030)

     Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
    • Pancreas

     

    • Middle East Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Africa Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    • Latin America Outlook (USD Billion, 2018-2030)

    Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)

    • Instruments
    • Reagents & Consumables

    Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)

    • Pre-Transplant
    • Post-Transplant

    Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)

    • Kidney
    • Liver
    • Heart
    • Lung
      • Pancreas
    Transplant Diagnostics Market Research Report- Global Forecast Till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials